Literature DB >> 29906795

National Survey of Neonatal Intensive Care Unit Medication Safety Practices.

Rachel G Greenberg1,2, P Brian Smith1,2, Carl Bose3, Reese H Clark4, C Michael Cotten1, Chris DeRienzo5.   

Abstract

OBJECTIVE: We conducted a detailed survey to identify medication safety practices among a large network of United States neonatal intensive care units (NICUs).
METHODS: We created a 53-question survey to assess 300 U.S. NICU's demographics, medication safety practices, adverse drug event (ADE) reporting, and ADE response plans.
RESULTS: Among the 164 (55%) NICUs that responded to the survey, more than 85% adhered to practices including use of electronic health records, computerized physician order entry, and clinical decision support; fewer reported adopting barcoding, formal safety surveys, and formal culture training; 137 of 164 (84%) developed at least one NICU-specific order-set with a median of 10 order-sets.
CONCLUSION: Among our survey of 164 NICUs, we found that many safety practices remain unused. Understanding safety practice variation is critical to prevent ADEs and other negative infant outcomes. Future efforts should focus on linking safety practices identified from our survey with ADEs and infant outcomes. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29906795     DOI: 10.1055/s-0038-1660837

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  Association between neonatal intensive care unit medication safety practices, adverse events, and death.

Authors:  Laura E Miller; Chris DeRienzo; P Brian Smith; Carl Bose; Reese H Clark; C Michael Cotten; Daniel K Benjamin; Chi D Hornik; Rachel G Greenberg
Journal:  J Perinatol       Date:  2020-10-08       Impact factor: 2.521

2.  Utilization of neonatal medication error prevention strategies: a clinical practice survey of Australian and New Zealand neonatal units.

Authors:  Nadine Matti; Minh-Nha R Nguyen; Cassandra Mosel; Luke E Grzeskowiak
Journal:  Ther Adv Drug Saf       Date:  2018-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.